Penumbra
PEN
$208.55
Share price
1.21%
Change (1 day)
-30.72%
Change (1 year)
Categories
Penumbra, Inc., is an American company that develops, manufactures and sells medical devices for neurovascular and vascular medicine applications.
Penumbra (PEN) - Cash on Hand
Cash on Hand as of December 2023 : $0.28 B
According to Penumbra's latest financial reports the company has $0.28 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Penumbra - Cash on Hand chart (from 2014 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $0.28 B | 53.8% |
| 2022-12-31 | $0.18 B | -26.23% |
| 2021-12-31 | $0.25 B | -3.76% |
| 2020-12-31 | $0.26 B | 39.83% |
| 2019-12-31 | $0.18 B | -5.72% |
| 2018-12-31 | $0.20 B | -6.39% |
| 2017-12-31 | $0.21 B | 66.67% |
| 2016-12-31 | $0.12 B | -13.47% |
| 2015-12-31 | $0.14 B | 188.7% |
| 2014-12-31 | $51.54 M | 276.89% |
| 2013-12-31 | $13.67 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Merit Medical MMSI | $0.58 B | 103.00% | 🇺🇸 USA |
 Inari Medical
NARI | $0.11 B | -60.08% | 🇺🇸 USA |